SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-063691
Filing Date
2019-11-14
Accepted
2019-11-14 06:55:50
Documents
14
Period of Report
2019-11-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1922678-1_8k.htm   iXBRL 8-K 26125
2 EXHIBIT 99.1 tm1922678d1_ex99-1.htm EX-99.1 7763
3 GRAPHIC tm1922678d1_ex99-1img001.jpg GRAPHIC 19096
  Complete submission text file 0001104659-19-063691.txt   238075

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA egrx-20191111.xsd EX-101.SCH 3183
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20191111_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20191111_pre.xml EX-101.PRE 22708
14 EXTRACTED XBRL INSTANCE DOCUMENT tm1922678-1_8k_htm.xml XML 3619
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 191216280
SIC: 2834 Pharmaceutical Preparations